A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease

Cited by (817)

Items 801–817 of 817

1. Impact de la personnalité sur la qualité de vie dans la maladie de Parkinson au stade des fluctuations motrices
   Mathilde Boussac · 2021
2. Towards the identification of targets and markers of Parkinson’s disease-associated neuroinflammation
   Cansu Yildirim-Balatan · 2021 · theses.fr (ABES)
3. Morbo di Parkinson: fisiopatologia, criteri diagnostici e segni clinici
   A. Marques · 2026 · EMC - Neurologia
4. Beyond the brain: a multisystem review of pathogenesis, comorbidity, and therapeutic progress in sporadic Parkinson’s disease
   Yang Li, Lijun Guo, Xiya Yu, Changgeng Peng · 2026 · Ageing and Neurodegenerative Diseases
5. Stereoselective effects of nicotine enantiomers on the gut-brain axis and neuroinflammation in a mouse model of Parkinson’s disease
   R X Liu, Yunu Ma, Yingyan Li, Xia Gao, Shu Wang, Lutao Xu, Guanglin Liu, Huan Chen, Min Ji, Hongwei Hou · 2026 · Frontiers in Aging Neuroscience
6. Disparities in Incident Parkinson’s Disease: A Comparison of Health Outcomes Using Inpatient versus Outpatient Claims Data
   Irene M. Faust, Alejandra Camacho‐Soto, Brittany Krzyzanowski, Jordan A. Killion, Brad Alan Racette · 2026 · Neuroepidemiology
7. Nicotine in Neurodegenerative and Neuropsychiatric Disorders: Mechanisms and Clinical Evidence
   Geir Bjørklund, Leonard Gurgas, Tony Hangan · 2026 · Neurochemical Research
8. Vascular Risk Factors and the Risk of Incident Parkinson’s Disease Among Stroke Survivors: A Nationwide Population-Based Cohort Study
   Seo Yeon Yoon, Hyun Im Moon, Jin‐Hyung Jung, Sang Chul Lee, Kyungdo Han, Yong Wook Kim · 2026 · Journal of Clinical Medicine
9. Ursodeoxycholic Acid and Parkinson's Disease Risk: An Emulated Target Trial in UK Electronic Health Records
   Chengsheng Ju, Anette E. Schrag, Camille Carroll, Xi Xiong, James Robert Carpenter, Oliver Bandmann, Thomas Foltynie, Li Wei · 2026 · Movement Disorders
10. Association of serum vitamin D deficiency and inadequate sunlight exposure with Parkinson's disease risk: A pilot study in Bangladesh
    Md. Rabiul Islam, Md Sahabuddin, Nusrat Hossain Sheba, Zenat Zebin Hossain · 2026 · Heliyon
11. Lifestyle medicine for neuroprotection: evidence and implementation in Asian contexts
    Sumin Kim, Seok Jong Chung, Soyeon Yoon, Bastiaan R. Bloem, Elbrich Postma, Ryul Kim, Shinsuke Fujioka, Yukiko Nagaishi, Onanong Phokaewvarangkul, Kye Won Park et al. · 2026 · Journal of Neural Transmission
12. Machine learning-based discovery and clinical validation of STX12 and INPP5D as plasma biomarkers for Parkinson’s disease
    Cuiyu Yang, Rongmin Huang, Sijun Li, Jingling Wang, Shushu Liang, Jinshan Huang, Dengxing Zheng, Xuemin Cheng, Mei Liang · 2026 · Scientific Reports
13. Twins Discordant for Parkinson’s Disease: A 10-Year Longitudinal Follow-Up of Mortality, Clinical and Lifestyle Features, Nutritional Status, and Dietary Habits
    Michela Barichella, Antonio Natale, Elena Contaldi, Luca Magistrelli, Emanuele Cereda, Carlotta Bolliri, Maria Carmela Macchione, Federica Invernizzi, Daniela Calandrella, Ioannis U. Isaias et al. · 2026 · Brain Sciences
14. Habitual Diet, Gut Microbiome Dysbiosis, and α‐Synucleinopathy Conversion in Isolated Rapid Eye Movement ( REM) Sleep Behavior Disorder
    Suyi Xie, Yuhua Yang, Shi Tang, Li Na Zhou, Jing Wang, Joey Wing Yan Chan, Brian Or, Ningning Li, Siyi Gong, Zhixuan He et al. · 2026 · Movement Disorders
15. BindingDB Entry 50006976: The Medicinal Chemistry of Caffeine.
    BindingDB · 2024 · UC San Diego
16. Common pesticides and the development of Parkinson's disease
    Rizwan Nisar · 2011 · OpenGrey (Institut de l'Information Scientifique et Technique)
17. Functional characterization of leucine-rich repeat kinase 2 (LRRK2) dimerization
    Christian L. Klein · 2008